T32 Doctoral Training

Regenerative Engineering of Musculoskeletal Tissues: A Convergence Doctoral Training Program

Overview

The Cato T. Laurencin Institute for Regenerative Engineering has been awarded the T32 Program Grant Regenerative Engineering of Musculoskeletal Tissues: A Convergence Doctoral Training Program by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, AR079114). This T32 program aims to educate, support and enhance the training of individuals dedicated to careers as independent translational and basic scientists in regenerative engineering. The program offers inter-disciplinary research training at UConn Health and UConn Storrs combining the fields of biomedical science and engineering.

The support provided is for 2-years of graduate training to 2 PhD students at the University of Connecticut (School of Medicine or School of Engineering) who meet the criteria set forth by award. The institute has also been awarded supplemental funding for 1-year of graduate training to 3 PhD students on this parent grant to support diversity.

Goals

The T32 Doctoral Training Program aims to educate, support, and enhance the training of individuals dedicated to careers as independent clinical translational and basic scientists in the field of regenerative engineering. The program offers inter-disciplinary research training at the University of Connecticut combining the fields of biomedical science and engineering. Trainees are selected from current UConn graduate students who have completed their first or second year of PhD training. Trainees will become experts in regenerative engineering and its foundations to work towards the alleviation of human disease and musculoskeletal injuries by means of tissue regeneration.

Funding

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, T32AR079114).

Leadership

Cato T. Laurencin, M.D., Ph.D.

Program Director and Principal Investigator

Lakshmi Nair, M.Phil., Ph.D., FNAI

Chair of the Executive Committee and Co-Investigator

Gualberto Ruaño, M.D., Ph.D.

Associate Director and Co-Investigator